Immediate Impact

1 from Science/Nature 56 standout
Sub-graph 1 of 25

Citing Papers

Acute lymphoblastic leukaemia
2024 Standout
Management of ALL in adults: 2024 ELN recommendations from a European expert panel
2024 Standout
8 intermediate papers

Works of Thomas Lipp being referenced

Immunochemotherapy with Rituximab Improves Molecular CR Rate and Outcome In CD20+ B-Lineage Standard and High Risk Patients; Results of 263 CD20+ Patients Studied Prospectively In GMALL Study 07/2003
2010
Early prediction of response in patients with relapsed or refractory Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ALL) treated with imatinib
2003
and 3 more

Author Peers

Author Last Decade Papers Cites
Thomas Lipp 133 89 31 51 9 172
Kirsten Bleckmann 133 116 17 33 12 184
Anna Ejduk 101 101 11 85 11 193
Jordi Ribera 114 99 19 41 15 143
M-C Béné 142 149 28 21 9 216
Joan Pijoan 155 114 13 107 10 237
Sharon Bergeron 141 53 36 69 10 278
Phyllis Warkentin 103 71 17 77 7 211
Montserrat Torrent 41 54 24 23 11 142
Hester de Groot‐Kruseman 232 122 21 56 7 272
Sabina Sufliarska 56 94 40 32 15 152

All Works

Loading papers...

Rankless by CCL
2026